Breakpoint Therapeutics

About:

Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs.

Website: https://www.breakpointtx.com

Twitter/X: Breakpointtx

Top Investors: Evotec, Medicxi, Taiho Ventures

Description:

Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. Their mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.

Total Funding Amount:

30M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hamburg, Hamburg, Germany

Founded Date:

2019-01-01

Contact Email:

info(AT)breakpointtx.com

Founders:

Jonathan Hollick

Number of Employees:

1-10

Last Funding Date:

2019-07-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai